Hello, Guest
Login
Sign Up
 
 

Micro Cap Stocks Rallying (DCTH, CCUR, SOL, HTCH, NBS)

 
 
Repost This

Pompano Beach, FL -- (SBWIRE) -- 02/04/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Delcath Systems, Inc. (NASDAQ:DCTH) added 6.63% and is trading at $1.61. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.

Can DCTH Continue To Move Higher? Find Out Here

Concurrent Computer Corporation (NASDAQ:CCUR) is higher 1.33% and is trading at $7.59. Concurrent Computer Corporation (Concurrent) is a provider of software, hardware and professional services for the video market, the media industry, and the high-performance, real-time market. Its business consists of two segments: products and services.

How Should Investors Trade CCUR Now? Find Out Here

ReneSola Ltd. (ADR) (NYSE:SOL) is higher 7.46% and is trading at $2.16. ReneSola Ltd (ReneSola) is a global manufacturer of solar wafers and producer of solar power products based in the People's Republic of China. ReneSola possess a global network of suppliers and customers that includes some of the global manufacturers of solar cells and modules.

Can SOL Extend Rally? Find Out Here

Hutchinson Technology Incorporated (NASDAQ:HTCH) is higher 1.51% and is trading at $3.04. Hutchinson Technology Incorporated (HTI) is a global technology manufacturer. The Company is a supplier of suspension assemblies for hard disk drives. The Company operates in two segments: the Disk Drive Components Division and the BioMeasurement Division.

How Should Investors React To HTCH Now? Find Out Here

Neostem Inc. (NYSE:NBS) added 0.68% and is trading at $0.664. NeoStem, Inc. (NeoStem), is a international biopharmaceutical company. The Company operates in three segments: Cell Therapy-United States; Regenerative Medicine- China and Pharmaceutical Manufacturing-China. The Company is a provider of adult stem cell collection, processing and storage services in the United States, enabling healthy individuals to donate and store their stem cells for personal therapeutic use.

Can NBS Extend Rally? Find Out Here

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com